|
Erythromycin StearateDrug - Erythromycin Stearate The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Erythromycin Stearate
Strength -
EQ 500MG BASE
Applicant -
BARR
New Drug Application (NDA) Number -
063179
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
May 15, 1990
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Barr Laboratories Inc
Erythromycin Stearate
Erypar Eq 250mg Base Tablet; Oral
Erypar Eq 500mg Base Tablet; Oral Erypar Eq 250mg Base Tablet; Oral Erythrocin Stearate Eq 125mg Base Tablet; Oral Erythrocin Stearate Eq 250mg Base Tablet; Oral Erythrocin Stearate Eq 500mg Base Tablet; Oral Erythromycin Stearate Eq 250mg Base Tablet; Oral Erythromycin Stearate Eq 500mg Base Tablet; Oral Bristamycin Eq 250mg Base Tablet; Oral Bristamycin Eq 250mg Base Tablet; Oral NewDrugInformation |